PIK3CA and breast carcinoma: To confirm if the combination of Spautin-1 and PI3K inhibition exhibits synergistic activity in PI3Ki-resistant breast cancer cell lines, we treated each of the parental and resistant cell lines with increasing concentrations of Spautin-1 and BYL719 alone or in combination.